research proposal on hypertension

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here .

Loading metrics

Open Access

Peer-reviewed

Research Article

Risk factors of the progression to hypertension and characteristics of natural history during progression: A national cohort study

Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

Affiliations Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea, Graduate School of Public Health, Korea University, Seoul, Korea

Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing

Affiliations Graduate School of Public Health, Korea University, Seoul, Korea, National Health Insurance Service, Wonju-si, Korea

Roles Conceptualization, Writing – original draft, Writing – review & editing

* E-mail: [email protected]

• Kwan Hong, 
• Eun Sun Yu, 
• Byung Chul Chun

• Published: March 17, 2020
• https://doi.org/10.1371/journal.pone.0230538
• Reader Comments

Although the high disease burden that results from cardiovascular complications of hypertension, factors related to the progression to hypertension in the normotensive population are not actively reported. The purpose of this study was to estimate the rate of the progression to hypertension and to reveal the associated risk factors.

The study included normotensive participants from the National Health Insurance Service-National Health Screening Cohort, and contained a 10% sample of all adults who received a national health screening test in either 2002 or 2003. At the end of the study in 2015, the patients were divided into two groups based on whether or not they progressed to hypertension. Cox proportional hazard modeling was performed to identify risk factors for progression. Subgroup analysis using logistic regression was employed to reveal factors influencing the different natural history of the progression.

Among the 75,335 included participants, the progression rate to hypertension was 66.39% (50,013), with an adjusted incidence rate of 8.62 per 100 person-year in the aged 40–64 group and 12.68 in the aged 65 or above group. Age, BMI, hemoglobin, and family history of hypertension and other diseases were related to the progression. Among the progression group, 78.21% (39,116) participants skipped a pre-hypertensive status; this group consisted of older females with lower pulse pressure and more alcohol consumption compared to people who had pre-hypertensive status before the progression.

Substantial risk factors for the progression to hypertension should be carefully managed even in normotensive participants who receive health screening tests.

Citation: Hong K, Yu ES, Chun BC (2020) Risk factors of the progression to hypertension and characteristics of natural history during progression: A national cohort study. PLoS ONE 15(3): e0230538. https://doi.org/10.1371/journal.pone.0230538

Editor: Tatsuo Shimosawa, International University of Health and Welfare, School of Medicine, JAPAN

Received: January 6, 2020; Accepted: March 2, 2020; Published: March 17, 2020

Copyright: © 2020 Hong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: We used publicly available data, which is a database created and managed by the National Health Insurance Corporation in Korea. However, even if the researcher accesses the data, the data is analyzed using the terminal connected to the institution server, and raw data is not directly extracted. Any researcher can access the database used by the authors through these procedures, and can be used by submitting a series of documents including a research proposal to NHISS (National Health Insurance Sharing Service). Anyone can access the same data by formal request to NHISS. The website to request the access of data and the contact number of the manager in NHISS (National Health Insurance Sharing Service) are as follows: URL: https://nhiss.nhis.or.kr/bd/ab/bdaba005iv.do Contact: +82-033-736-2431, 2433

Funding: The authors received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Hypertension is the leading component of global disease burden and acts as a major cause of cardiovascular diseases [ 1 ]; a higher mortality in hypertensive population is well known in many countries through national level studies [ 2 – 4 ]. However, the incidence and prevalence of hypertension is difficult to measure naturally, given its asymptomatic nature [ 5 ]. Many studies that have aimed to determine the prevalence of hypertension by screening or survey have concluded that 20%–45% of the total population worldwide has hypertension [ 6 – 9 ]. However, the definition of hypertension changed in the 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines [ 10 ], which caused confusion in the diagnosis and treatment of patients with stage 1 hypertension, previously referred to as pre-hypertension [ 11 ]. In this complex situation, and due to the dynamic nature of blood pressure, it is difficult to measure blood pressure in a consistent way [ 12 ] and classify the blood pressure status in the general population.

Nevertheless, classifying and revealing risk factors for the progression to hypertension is quite meaningful considering its contribution to health status. Since the new diagnostic criteria is not applied to all countries, there are currently a limited number of studies that are attempting to determine the risk factors of the progression to hypertension (stage 1 or 2 hypertension as referred to in the 2017 ACC/AHA hypertension guidelines) or comparing the groups who passed different steps of the natural history (those who skipped pre-hypertensive step or not). Indeed, only the natural history of the stage 1 hypertension group (previously called the pre-hypertensive group) was revealed in the majority of studies [ 13 – 17 ]. Therefore, this study aims to identify the incidence rate and risk factors for the progression from normotensive to hypertensive using the national cohort study. Additionally, we aimed to reveal factors associated with the different natural history of the progression group.

Materials and methods

Study population.

Data from The National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea were used in this study. Fig 1 shows overall population and procedure of this study. The data included 514,795 participants who were randomly sampled from 10% of the population who received the health screening in 2002 or 2003 and followed up until 2015 [ 18 ]. Given the sensitive nature of the data, requests to access the dataset from qualified researchers may be sent online to the National Health Insurance Sharing Service system in Korea [ 19 ]. For the re-analysis of this study, the codes for the analysis is available from the first author on request.

• PPT PowerPoint slide
• PNG larger image
• TIFF original image

https://doi.org/10.1371/journal.pone.0230538.g001

The health screening program in Korea provides health check-ups biannually to all subjects aged 40–79 years who are covered by the national health insurance. These data include all hospital data for which insurance was claimed. Among this population, we constructed our cohort as the following definition: People (1) who received health screenings in 2003 or 2004 and were classified as normotensive, (2) who had not been previously diagnosed with hypertension at a hospital in the year before enrollment, and (3) who had no hospital diagnosis of hypertension before being classified with hypertension by health screening. We followed the criteria from the 2017 ACC/AHA hypertension guideline for the classification of hypertension.

Study procedure

Using the regular blood pressure measurement of participants by health screening tests, we classified their blood pressure status as normotensive (< 120/80 mmHg), pre-hypertensive (120–129/< 80 mmHg), stage 1 hypertensive (130–139/80–89 mmHg), and stage 2 hypertensive (≥ 140/90 mmHg) in each measurement in order to follow-up their natural history. Only normotensive participants at registration were included in analysis in this study. After 14 years of follow-up, the study population was grouped according to whether they had progressed to hypertension at the end. After estimating the incidence rate using the number of hypertensive patients and the total follow-up years of all participants, we extracted the possible risk factors for progression in each participant. Demographic factors such as age and sex, factors associated with health behaviors such as smoking status, alcohol consumption, and exercise status, past history of diabetes, family history of diseases including hypertension and stroke, and measured variables from health screening tests such as BMI, hemoglobin, total cholesterol, fasting glucose, and pulse pressure were included in the analysis. We conducted subgroup analysis in the progressed group in order to determine any difference in natural history between people who are classified as pre-hypertension during biannual follow-up and people who skipped this status. The former indicated a slower step-by-step progression to hypertension.

Statistical analysis

To identify the risk factors for progression to hypertension, chi-square statistics for categorical variables and t-test for continuous variables were used for the selection of factors at the level of 0.1 by p-values, stratified by sex. The selected risk factors were included in a multivariable Cox proportional regression model using a stepwise selection method. The hazard ratios and 95% confidence intervals of each risk factor were presented, and the adequacy of the final model was checked by AIC (Akaike Information Criterion) statistics. The linearity and proportionality of the model was verified through the log-cumulative hazard plot and Shoenfeld residual [ 20 ]. Due to missing values of each of the factors, we evaluated the model stability by subtracting one variable each and comparing it with the total model. The crude and adjusted incidence rate was estimated additionally, stratified by age and sex.

The progression group was selected for the subgroup analysis. This group was further divided into two groups based on whether or not the participants were classified as pre-hypertensive before hypertension. Similarly, the difference in characteristics between the two groups was tested by chi-square statistics and t-tests and selected for multivariate analysis at the level of p-value < 0.1. Logistic regression analysis was used to reveal the adjusted effect of each risk factor and the odds ratio with 95% confidence interval are presented. AUC (Area Under the Curve) and the Hosmer-Lemeshow test were used to assess the fitness of the final model [ 21 ].

Additionally, Pearson correlation coefficients between continuous variables, including age, pulse pressure, BMI, total cholesterol, and fasting glucose, are estimated. All of them were under 0.3, indicating low correlation among these values. Statistical significance of both multivariate analyses was accepted with a p-value = 0.05, and all statistical analysis was conducted using SAS version 9.4 (SAS Institute Inc).

Ethical approval

This project was approved by the institutional review board of Korea University (IRB: KUIRB-2018-0064-01). Informed consent was waived because personal information was deleted from the dataset.

Among the 425,865 individuals who received health screening tests in 2003 or 2004, 89,378 (20.99%) were normotensive and 75,335 participants who met the inclusion criteria were included in the study. At the end of the follow-up in 2015, 50,013 (66.39%) participants proceeded to hypertension. The crude and adjusted incidence rate of hypertension is presented in Table 1 ; the incidence rate was 8.93 per 100 person-year in individuals younger than 65 years old and 13.18 per 100 person-year in individuals older than 65 years old. The incidence rate ratio between the two age groups was 1.47 (95% confidence interval: 1.41–1.53).

https://doi.org/10.1371/journal.pone.0230538.t001

Risk factors for the progression to hypertension

The baseline characteristics and the univariate analysis of the study population are described in Table 2 . The mean age of the study population was 50.25±8.04 (mean±standard deviation) years old, and the people who proceed to hypertension were slightly older (50.57±8.14 compared to 49.63±7.80). The proportion of males was significantly higher in the progression group, accounting for 46.58% compared to 34.42% of the non-progressing group. Additionally, almost all of the remaining factors were different in either their mean or percentage in the two groups. The mean blood pressure and the mean pulse pressure were higher in the progressing group, 107/67 (pulse pressure 39.97) mmHg in the progressing group and 105/65 (pulse pressure 39.41) in the non-progressing group. The BMI was also higher in the progressing group, with a mean BMI of 23.16±2.70 kg/m 2 in the progressing group compared to 22.36±2.55 kg/m 2 in the non-progressing group. The total cholesterol, hemoglobin, and fasting glucose were also higher in the progressing group (p < 0.05). The past history of diabetes was not significantly different in the two groups, but more people tended to have diabetes in the progressing group (1.99% compared to 1.84%). In terms of the family history of diseases, hypertension and stroke were positively related with the progression to hypertension, while other histories, such as diabetes, cancer, and liver disease, related negatively. Current smokers progressed to hypertension more than non-smokers (21.35% compared to 17.24%).

https://doi.org/10.1371/journal.pone.0230538.t002

Since the sex of participants were strongly related with health behaviors such as smoking and alcohol consumption, we stratified the study population by sex and selected the possible risk factors, age, BMI, hemoglobin, family history of hypertension/cancer/liver disease and alcohol consumption in males and age, pulse pressure, BMI, hemoglobin, fasting glucose, family history of diabetes/cancer/liver disease, smoking status and physical exercise in females, in each stratum by univariate analysis. After the selection, the adjusted hazard ratio and 95% confidence intervals are presented in Table 3 , using Cox proportional regression modeling by the stepwise selection method, considering the time-dependent effect of age. In males, age, BMI, hemoglobin, family history of hypertension, and alcohol consumption positively influenced the progression to hypertension (adjusted hazard ratios: 1.013, 1.051, 1.019, 1.106, and 1.130). Family history of cancer or liver disease negatively related to the progression with adjusted hazard ratios of 0.928 and 0.911, respectively. Similarly, in females, age, BMI, and hemoglobin were positively related (adjusted hazard ratios: 1.033, 1.043, and 1.028), but family history of hypertension and alcohol consumption were not included in the final model. In addition, pulse pressure and fasting glucose affected the progression in females (adjusted hazard ratios: 1.005 and 1.001). Family history of diabetes, cancer, and liver disease were negatively related with the progression in females, with measured hazard ratios of 0.948, 0.920, and 0.838, respectively. In females, current smoking status and physical exercise lowered the progression to hypertension, with adjusted hazard ratios of 0.559 and 0.928, respectively.

https://doi.org/10.1371/journal.pone.0230538.t003

People who skipped pre-hypertensive status and proceeded to hypertension directly

Table 4 shows the subgroup analysis of the progression group, comparing people with and without pre-hypertensive status during biannual follow-up; 78.21% (39,116) of the progression group skipped pre-hypertensive status. The adjusted odds ratios were measured by logistic regression analysis with the stepwise selection method after selecting the included variables by univariate analysis. The mean age was higher in the progression group (50.85 years old compared to 49.58 years old), with an adjusted odds ratio of 1.020 (95% confidence interval: 1.017–1.023). Males, people with higher pulse pressure, and lower alcohol consumption had increased pre-hypertensive status (adjusted odds ratios: 0.912, 0.977, and 0.805, respectively).

https://doi.org/10.1371/journal.pone.0230538.t004

The Cox proportional hazard model we used in Table 3 was selected considering minimal AIC statistics after stepwise variable selection. The difference of AIC statistics of the final model and the null model was 521.07 in males and 1738.47 in females. After testing the linearity and proportionality, time-dependent interaction terms of age and pulse pressure in males and age, smoking status, BMI in females were included in the final model. The logistic regression model used in Table 4 used stepwise selection method to select variables and tested for goodness-of-fit by Hosmer-Lemeshow test, resulted chi-square = 5.82, df = 8 and p-value = 0.67. The overall AUC was 0.56 (95% confidence interval = 0.55–0.57).

In this national cohort-based study, the progression rate from normal to hypertension was 66.39%, with an adjusted incidence rate of 8.62 per 100 person-year in middle-aged people and 12.68 per 100 person-year in elderly people; this was a much larger proportion than previous studies have demonstrated [ 5 , 9 , 15 , 22 ], including the population study in Japan, which reported a total of 40.7% of progression to hypertension at the 12-year follow up [ 17 ]. To the best of our knowledge, this is the first study to report the progression rate and risk factors of the progression to hypertension in Korea. The results of the current study indicate a substantial risk of an increased hypertensive population. Since there is strong evidence of the cardiovascular risk of the population who are diagnosed with hypertension by the 2017 ACC/AHA diagnostic criteria [ 23 ], the management of hypertension may also change to include the larger population at risk.

Identifying risk factors of the progression to hypertension in the normotensive population is more informative than simply comparing hypertensive and normotensive groups because it can actually reflect what risk factors are to be found and managed through screening programs. Age, BMI, and hemoglobin level, which showed an increase in progression in both males and females, can be applied as the observed indicator of the progression, even in the normotensive period. In agreement with our results, there is considerable evidence of these factors as a possible risk factors of hypertension [ 16 , 24 – 28 ].

Since this study included only normotensive population at the enrollment, there were minimal effect of baseline blood pressure in results, decreasing only 1.9 AIC statistics with inclusion. Instead of adjusting baseline blood pressure, we used pulse pressure as the risk factor and showed a little increase of the progression to hypertension with adjusted hazard ratio 1.005 in females. There were two factors that showed a positive relation with progression in females: pulse pressure and fasting glucose. Although these factors are known to increase progressively with age [ 29 , 30 ], this result is important since adjustments were made to account for the time-dependent age effect. Although this difference has not been previously discussed, it indicates that females may be more vulnerable to fasting glucose level or pulse pressure.

In addition, exercise habits seemed to only be protective in females; however, the questionnaire only asked for the frequency of exercise and did not consider the intensity or time. Therefore, considering previous studies that have revealed the effect of exercise in the protection from hypertension [ 28 , 31 , 32 ], this result should be interpreted with caution. Alcohol consumption is widely known as a risk factor for hypertension [ 33 , 34 ]; the results of the current study demonstrated an increased risk of hypertension in males with high alcohol consumption, but the same was not true for females. However, this may be because only 1.61% of females are classified as heavy alcohol consumers in our population. Surprisingly, in females, smoking showed an inverse relationship with the progression to hypertension. Indeed the potential relationship of smoking and hypertension remains controversial [ 35 , 36 ], and further studies need to be conducted with a focus on the pathophysiology.

Family history of hypertension did increase the progression in males, showing that genetic predisposition can still be considered as a major risk factor [ 37 , 38 ]. However, the family history of other diseases showed negative relationship with the progression; this infers that diseases such as diabetes or cancer can affect the health behaviors of individuals, leading to the control of blood pressure.

Subgroup analysis showed the difference between people who had pre-hypertensive status or not in the study period. In the group that skipped pre-hypertensive status, the rate of progression might be faster than the other group, or their health behavior might not be good enough to receive biannual health screening. Although there may be misclassification due to the latter, the results can have sufficient value since this was the first attempt to compare two groups with different natural histories of hypertension. After considering interaction and the effect of covariates, age, sex, pulse pressure, and alcohol consumption remained possible risk factors for directly proceeding to hypertension and skipping pre-hypertensive status. In other words, females with increase alcohol consumption, lower pulse pressure, and older age were at greater risk of skipping pre-hypertensive status.

There are several limitations to this study. Firstly, this study only included data from the national health screening result and hospital data, so other known risk factors, such as diet [ 39 – 41 ], cannot be considered; as an alternative to this, BMI and total cholesterol were included in the analysis. Also, the national health screening only included exercise pattern of participants as the frequency. The lack of information about the daily amount of physical activity might have affected the study result since there is the intervention study that revealed the protective effect of regular aerobic exercise. Lastly, some factors in the health screening test, such as family history or health behavior, were self-reported, which may be inaccurate and also lead to a higher missing rate (up to 9.7%). However, after subtracting each variable in the analysis in order to determine the potential bias, there were no change in the direction or significance of the final model.

Conclusions

This large national cohort-based study revealed several potential risk factors of the progression to hypertension, including family history, health behavior, and objective values such as BMI and hemoglobin. Through this result, medical services can not only find out high-risk population for the progression to hypertension in pre-hypertensive people, but also manage them focusing on modifiable factors such as BMI. Furthermore, a discussion of the progression group comparing different natural history may help to develop a more efficient management and screening system for hypertension.

Acknowledgments

We are indebted to the National Health Insurance Sharing Service for providing the national cohort data for the analysis.

• View Article
• PubMed/NCBI
• Google Scholar
• 19. National Health Insurance Sharing Service. [Cited 2019 November 20]. Available from: https://nhiss.nhis.or.kr .
• 20. Collett D. Modelling Survival Data in Medical Research, third edition. CRC press; 2015.

An official website of the United States government

Here’s how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS A lock ( A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

• Heart-Healthy Living
• High Blood Pressure
• Sickle Cell Disease
• Sleep Apnea
• Information & Resources on COVID-19
• The Heart Truth®
• Learn More Breathe Better®
• Blood Diseases and Disorders Education Program
• Publications and Resources
• Blood Disorders and Blood Safety
• Sleep Science and Sleep Disorders
• Lung Diseases
• Health Disparities and Inequities
• Heart and Vascular Diseases
• Precision Medicine Activities
• Obesity, Nutrition, and Physical Activity
• Population and Epidemiology Studies
• Women’s Health
• Research Topics
• Clinical Trials
• All Science A-Z
• Grants and Training Home
• Policies and Guidelines
• Funding Opportunities and Contacts
• Training and Career Development
• Email Alerts
• NHLBI in the Press
• Research Features
• Past Events
• Upcoming Events
• Mission and Strategic Vision
• Divisions, Offices and Centers
• Advisory Committees
• Budget and Legislative Information
• Jobs and Working at the NHLBI
• Contact and FAQs
• NIH Sleep Research Plan
• < Back To Research Topics

High Blood Pressure Research

Language switcher.

As part of its broader commitment to research on cardiovascular diseases, the NHLBI leads and supports research and programs on hypertension (high blood pressure). The NHLBI has funded several studies and programs to help develop new treatments for high blood pressure, many of which focus on women’s health, lifestyle interventions, and health disparities. Current studies aim to prevent pregnancy complications and improve blood pressure among people who are at high risk.

NHLBI research that really made a difference

Find  funding opportunities  and  program contacts  for high blood pressure research.

• The Dietary Approaches to Stop Hypertension (DASH) Sodium Trial showed that lowering sodium as part of a healthy eating plan significantly lowers blood pressure for people with high blood pressure. Researchers saw the greatest change when lowering sodium was combined with eating a diet rich in fruits and vegetables and low in saturated fat.
• The NHLBI’s Systolic Blood Pressure Intervention Trial (SPRINT) study found that treating to a lower systolic blood pressure target — less than 120 mm Hg — helped lower deaths from heart attack and stroke, particularly among older people who have high blood pressure. These findings informed the latest high blood pressure guidelines in 2017. A follow-up study called SPRINTMIND found that treating to this lower blood pressure target also reduced mild cognitive impairment , a condition that can lead to dementia.
• The NHLBI Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT ) was the largest hypertension clinical trial ever conducted, involving more than 600 clinics and 42,000 participants. The study compared the effectiveness of three commonly used blood pressure-lowering medicines (a calcium channel blocker, amlodipine; an ACE-inhibitor, lisinopril; and an alpha-receptor blocker, doxazosin) with a diuretic, chlorthalidone. The trial concluded that the diuretic worked better than the other medicines to manage high blood pressure and prevent stroke, as well as some types of heart disease, especially heart failure.

Current research funded by the NHLBI

Our Division of Cardiovascular Sciences and its Vascular Biology and Hypertension Branch oversee much of the research we fund on the regulation of blood pressure. 

Current research on the treatment of high blood pressure

NHLBI-supported research has led to creating and updating blood pressure treatments that have helped people around the world. High blood pressure affects millions of U.S. adults. We continue to support work on new treatments and also new approaches that tailor the right treatment to the right patient.

• Researchers in the NHLBI-funded Levy Lab are studying the role of genetics in cardiovascular disease using resources from the Framingham Heart Study to develop promising blood pressure medicines and treatments.
• The NHLBI funds research into the connection between inflammation and high blood pressure . Better understanding of the causes of hypertension helps researchers develop treatments to improve blood pressure management and prevent early death from cardiovascular disease.
• The NHLBI supports research to improve adherence to long-term cardiovascular medicines that help regulate blood pressure. Researchers use pharmacy data to identify patients who fail to refill their medicines. They then test whether reminders using text messages or interactive chat bots can improve medicine adherence.
• The NHLBI funds research into the connection between the microbiome and high blood pressure . One study found that bacterial strains in the mouth were linked to high blood pressure in older women. Another study showed that intermittent fasting in an animal model could reduce hypertension by reshaping the gut microbiota. 
• Findings from the Offspring Cohort of the Framingham Heart Study (FHS) and the Coronary Artery Risk Development in Young Adults (CARDIA) study showed a close association between hypertension and late-onset epilepsy and other brain changes, respectively, which may increase the risk of cognitive decline later in life.
• A clinical trial called Treating Resistant Hypertension Using Lifestyle Modification to Promote Health (TRIUMPH) showed that lifestyle modification, such as following the DASH eating plan, could significantly reduce blood pressure even in patients with resistant hypertension. Another study found that DASH was effective in adolescents with high blood pressure. 
• A clinical trial Chlorthalidone in Chronic Kidney Disease (CLICK) showed that the diuretic chlorthalidone can improve blood pressure control in patients with advanced chronic kidney disease. 
• A recent meta-analysis showed that use of anti-hypertension medicines that can cross the blood-brain barrier is linked to more cognitive benefits than those that do not cross the barrier. 

Find more NHLBI-funded studies on the  high blood pressure treatment at NIH RePORTER.

Find out more about how the DASH diet and exercise help fight resistant high blood pressure.

Current research on women’s health and high blood pressure

NHLBI-supported research has helped reveal how pregnancy complications, including high blood pressure, affect the long-term health of women and their children.

• One study found that women who have a preterm birth have a greater chance of later developing high blood pressure.
• The NHLBI continues to fund the nuMoM2b Heart Health Study , which helps scientists understand how cardiovascular disease starts and develops in women. Researchers, funded by the NHLBI and the Eunice Kennedy Shriver National Institute of Child Health and Human Development,  found that women who developed complications during their first pregnancy were more likely to have had higher levels of blood sugar, blood pressure, and inflammation during their first trimester than women who did not develop complications. They are also more likely to develop chronic hypertension within 7 years after delivery. The study is also looking at the  links between pregnancy, sleep health, and cardiovascular health .
• The NHLBI’s  CHAP Maternal Follow-up Study is examining the impact of treatment for preeclampsia and high blood pressure during pregnancy on a woman’s future chance for developing cardiovascular disease. The results will help identify the best ways to improve the health of women younger than age 40 who have mild, long-term high blood pressure.

Find more NHLBI-funded studies on  women’s health and high blood pressure at NIH RePORTER. 

Current research on health disparities and high blood pressure

Black adults in the United States have a higher prevalence of high blood pressure than other racial and ethnic groups. The NHLBI supports research to understand and reduce high blood pressure disparities, as part of our broader commitment to addressing  health disparities and inequities .

Other studies and research areas we fund to understand and lower the impacts of health disparities are listed below:

• Our RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study reaches 4,000 young and middle-aged men and women from different racial and ethnic groups living in poor rural counties in four southern states. The goal of the study is to understand what causes the high rates of heart and lung disease in these regions and how to lower those rates and improve prevention efforts .
• Co-funded by the NHLBI  and the NIH Office of Research on Women’s Health, the Maternal Health Community Implementation Program (MH-CIP) supports community-engaged implementation research, working with affected communities to improve heart, lung, blood, and sleep health before, during, and after pregnancy. MH-CIP focuses on bringing effective maternal health interventions — including projects related to hypertension — into communities severely impacted by maternal health disparities.
• An NHLBI-funded study aims to improve implementation of the SPRINT findings in underserved populations. The study puts into practice a plan for blood pressure treatment at 30 clinics that serve people with little or no income in southeast Louisiana.  The study’s findings will help lower barriers to blood pressure treatment faced by people who experience poverty.

Find more NHLBI-funded studies on  high blood pressure and health disparities at NIH RePORTER. 

High blood pressure research labs at the NHLBI

The NHLBI  Division of Intramural Research and its  Cardiovascular Branch conduct research on diseases that affect the heart and blood vessels, including high blood pressure. Other Division of Intramural Research groups, such as the Center for Molecular Medicine and  Systems Biology Center , perform research on heart and vascular diseases.

Related programs

• In 2023, the NHLBI convened the  Transforming Hypertension Diagnosis and Management in the Era of Artificial Intelligence (AI) workshop to discuss gaps and opportunities in leveraging AI technologies for hypertension diagnosis and management.
• Nurse case management, in which a nurse provides behavioral counseling and monitors blood pressure through telehealth, adjusting blood pressure medications as needed 
• Community health workers providing health coaching and information about community resources 

        Read more about the DECIPHeR program .

• In 2019, the NHLBI convened the HIV-associated Comorbidities, Co-infections & Complications Workshop , which led to strategies that support more research into the diseases, infections, and complications related to HIV. People with HIV have a higher risk of developing high blood pressure, even if they actively manage HIV infection with medicine.

Explore more NHLBI research on high blood pressure

The sections above provide you with the highlights of NHLBI-supported research on high blood pressure. You can explore the full list of NHLBI-funded studies on the NIH RePORTER .

To find more studies:

• Type your search words into the  Quick Search  box and press enter. 
• Check  Active Projects  if you want current research.
• Select the  Agencies  arrow, then the  NIH  arrow, then check  NHLBI .

If you want to sort the projects by budget size — from the biggest to the smallest — click on the  FY Total Cost by IC  column heading.

Living with Hypertension: A Qualitative Research

Affiliations.

• 1 Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
• 2 Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
• PMID: 28670584
• PMCID: PMC5478742

Background: Hypertension affects many aspects of the patients' life. Factors such as attitudes, beliefs and experiences, and social and cultural conditions of patients have effective roles in hypertension treatment process. The aim of this research was to explore perspectives and experiences of patients with hypertension while living with this disease.

Methods: This is a qualitative research using content analysis approach. 27 hypertensive patients who referred to hospitals affiliated to Tehran University of Medical Sciences were selected based on purposive sampling, and semi-structured interviews were carried out. Graneheim and Lundman's approach was used for analysis of data and Lincoln and Guba's criteria were used to confirm the trustworthiness of the study's findings.

Results: Experiences of the participants were divided into three main categories as follows: (1) disease shadow; (2) dual understanding of the effect of drug therapy consisting of two sub-categories known as ''perceived benefits,'' ''negative consequences''; and (3) facing the disease that includes the two subcategories of ''Compatibility'' and ''Negligence and denial''.

Conclusion: Based on the findings, patients with hypertension had experienced many physical, psychological, social, familial and spiritual problems due to the disease and their cultural context. These patients obtained positive experiences following the compatibility with hypertension. Comprehensive planning tailored to the cultural, social context and their beliefs is necessary to solve problems in these patients.

Keywords: Qualitative research; Experience; Hypertension.